APTEVO THERAPEUTICS INC
Q2 2026 13F Holders
Symbol
APVO
CUSIP
03835L702
Type
Equity
Class
COM SHS NEW
Num filings
9
Total reported value, excl. options
$224 k
Compare 2026 Q2 to
2026 Q1
2025 Q4
2016 Q4
2016 Q3
Manager
Report Date
Value ($000)
Shares
Option Type